Indrayani Biotech Limited has intimated the Bombay Stock Exchange about an upcoming Board of Directors meeting scheduled for Monday, 17 August 2026. The intimation is made pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board meeting agenda includes:
- Approval of audited financial statements of the company for the Quarter and Financial Year ended March 31, 2026 along with notes thereon
- Authorization of directors to sign the approved financial statements
- Taking on record the Auditors' Report on the financials for the Financial Year ended March 31, 2026
- Approval of the Audited Financial Results for the Quarter and financial year ended March 31, 2026 for dissemination to stock exchanges
- Approval of the text of advertisement for publication in newspapers
- Consideration of any other business with permission of the chair
The company has requested the exchange to take this information on record and disseminate it on their website.